1. Home
  2. GBIO vs MNY Comparison

GBIO vs MNY Comparison

Compare GBIO & MNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • MNY
  • Stock Information
  • Founded
  • GBIO 2016
  • MNY 2014
  • Country
  • GBIO United States
  • MNY Singapore
  • Employees
  • GBIO N/A
  • MNY N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • MNY
  • Sector
  • GBIO Health Care
  • MNY
  • Exchange
  • GBIO Nasdaq
  • MNY Nasdaq
  • Market Cap
  • GBIO 29.2M
  • MNY 43.9M
  • IPO Year
  • GBIO 2020
  • MNY N/A
  • Fundamental
  • Price
  • GBIO $0.41
  • MNY $1.67
  • Analyst Decision
  • GBIO Strong Buy
  • MNY Strong Buy
  • Analyst Count
  • GBIO 4
  • MNY 1
  • Target Price
  • GBIO $7.33
  • MNY $4.00
  • AVG Volume (30 Days)
  • GBIO 2.0M
  • MNY 522.8K
  • Earning Date
  • GBIO 08-06-2025
  • MNY 06-13-2025
  • Dividend Yield
  • GBIO N/A
  • MNY N/A
  • EPS Growth
  • GBIO N/A
  • MNY N/A
  • EPS
  • GBIO N/A
  • MNY N/A
  • Revenue
  • GBIO $24,556,000.00
  • MNY $71,649,746.00
  • Revenue This Year
  • GBIO N/A
  • MNY $16.97
  • Revenue Next Year
  • GBIO N/A
  • MNY $19.35
  • P/E Ratio
  • GBIO N/A
  • MNY N/A
  • Revenue Growth
  • GBIO 146.47
  • MNY N/A
  • 52 Week Low
  • GBIO $0.30
  • MNY $0.55
  • 52 Week High
  • GBIO $3.65
  • MNY $1.88
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 50.87
  • MNY 78.93
  • Support Level
  • GBIO $0.32
  • MNY $1.22
  • Resistance Level
  • GBIO $0.59
  • MNY $1.88
  • Average True Range (ATR)
  • GBIO 0.05
  • MNY 0.19
  • MACD
  • GBIO 0.02
  • MNY 0.07
  • Stochastic Oscillator
  • GBIO 34.16
  • MNY 80.33

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About MNY MoneyHero Limited

MoneyHero Ltd is a personal finance aggregation and comparison company in Greater Southeast Asia. The firm is involved in the operation of online financial comparison platforms and related services for credit cards, personal loans, mortgages, insurance, and other financial products, connecting the providers of these products with well-matched and ready-to-transact consumers and generating revenue directly from these providers for placing their products on its platforms and providing insurance brokerage, marketing and events-related services. Geographically it operates in Singapore, Hong Kong, Taiwan, Malaysia and the Philippines.

Share on Social Networks: